Influence of Artificial Intelligence on Drug Discovery & Development, 2018 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Oct 1, 2018--The “Influence of Artificial Intelligence on Drug Discovery and Development” report has been added to ResearchAndMarkets.com’s offering.
This report outlines the impact of artificial intelligence (AI) on the global drug discovery and development landscape. Berg Health’s precision medicine platforms and a clinical overview of the company’s pipeline have been profiled in the report. Furthermore, IP trends, research aspects, and AI-medicine strategies have also been described.
Key Topics CoveredArtificial Intelligence - Overall Impact and Opportunity Leverage AI-based Precision Medicine AI-based Precision Medicine Innovation Scouting AI-driven Medicine: Approaches, Features, and Targeted Areas Clinical Trial Analysis: Bergh Health’s Pipeline Key Contacts
For more information about this report visit https://www.researchandmarkets.com/research/lc5sxv/influence_of?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181001005451/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Drug Discovery
INDUSTRY KEYWORD: TECHNOLOGY SOFTWARE HEALTH CLINICAL TRIALS PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 10/01/2018 06:53 AM/DISC: 10/01/2018 06:53 AM